MedPath

A Comparison of Sequential Compression Devices and Foot Pumps in the Obstetric Population

Not Applicable
Terminated
Conditions
Thrombophilia
Interventions
Device: Kendall sequential compression device, model 9525
Device: Kendall A-V foot impulse pump, model 6060
Registration Number
NCT00356434
Lead Sponsor
Johns Hopkins University
Brief Summary

The researchers at Johns Hopkins University believe that the foot pump will be superior to sequential compression devices in comfort and patient compliance which may increase provider efforts to prevent deep vein thrombosis (DVT) in pregnancy.

Detailed Description

The investigators will be comparing sequential compression devices (SCDs) to foot pumps to determine if foot pumps will be better tolerated by obstetric patients, both antepartum and intrapartum. Patients in whom thromboembolic prophylaxis is deemed necessary and ordered by the treating physician, who agree to participate in the study will be randomly assigned to receive SCDs or the foot pump as part of their thromboembolic prophylaxis regimen. The investigators will administer a questionnaire to assess patients' satisfaction and comfort with each device and they will be asked to complete a log of hours they wore their assigned device for a 7 day period (or as long as they are prescribed). Random spot checks to verify compliance will be performed.

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
11
Inclusion Criteria
  • Pregnant
  • Bedrest
  • Thrombophilia
  • Prescribed DVT prophylaxis
Exclusion Criteria
  • Active DVT

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
2Kendall sequential compression device, model 9525Patients will have the Kendall,sequential compression device, model 9525 applied to the lower extremities to prevent DVT
1Kendall A-V foot impulse pump, model 6060Patients will have the Kendall, A-V foot impulse pump, model 6060 applied to their lower extremities to prevent DVT
Primary Outcome Measures
NameTimeMethod
Patient Compliancefor 1-7 days during hospitalization

Nurse conducting random checks throughout hospital stay and events of noncompliance will be recorded

Comfort Levelonce during first 7 days of hospitalization

Scale of 1-10 (1 being very uncomfortable and 10 being very uncomfortable) describing level of comfort during the time of device use (composite score of heat, softness, discomfort).

Secondary Outcome Measures
NameTimeMethod
DVT Preventionup to 3 months

positive DVT on ultrasound

Trial Locations

Locations (2)

Johns Hopkins Hospital

🇺🇸

Baltimore, Maryland, United States

Johns Hopkins Bayview Medical Center

🇺🇸

Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath